Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors

SU5416 is a novel small molecule tyrosine kinase inhibitor of the VEGF receptors 1 and 2. A phase I dose escalation study stratified by concurrent use (stratum II) or absence (Stratum I) of enzyme-inducing anticonvulsant drugs was undertaken to estimate the maximum-tolerated dose (MTD) and to descri...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kieran, Mark W., Supko, Jeffrey G., Wallace, Dana, Fruscio, Robert, Poussaint, Tina Young, Phillips, Peter, Pollack, Ian, Packer, Roger, Boyett, James M., Blaney, Susan, Prados, Michael, Geyer, Russ, Friedman, Henry, Goldman, Stewart, Kun, Larry E., MacDonald, Tobey
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2775441/
https://ncbi.nlm.nih.gov/pubmed/19065567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21873
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы